An investigation of the relationship between the pharmaceutical industry, medical profession and medical practitioners

近年来，制药业和医疗行业之间相互作用的数量和范围迅速扩大。虽然这有可能促进研究、教育和医疗保健，但这种互动可能会不适当地服务于商业目标，并最终损害患者和整个社会的最佳利益。大多数主要的医疗和制药机构都发布了关于医疗专业和制药业之间关系的指导方针和政策声明。到目前为止，大多数辩论都是以个人观察或专业意见的形式进行的，很少有关于医疗行业相互作用的客观研究。这个项目旨在研究制药业、医疗专业和医生之间的关系。具体地说，该项目的目的是确定目前存在的这种关系以及专业机构的指导方针是否在合理的道德标准、实证研究和社会观点方面是适当的。这项研究的结果将使我们能够评估目前的准则，并酌情制定进一步的准则和常规程序。

In recent years there has been a rapid expansion in the number and range of interactions between the pharmaceutical industry and the medical profession. While this has the potential to advance research, education and health care, there are risks that such interactions may inappropriately serve commercial objectives and ultimately compromise the best interests of patients and society in general. Most major medical and pharmaceutical organisations have released guidelines of policy statements on the relationship between the medical profession and the pharmaceutical industry. To date most debate has taken the form of personal observations or professional opinion , and there has been little objective research into medical industry interactions. This project aims to examine the relationship between the pharmaceutical industry, the medical profession and the medical practitioners. Specifically, the aim of this project is to establish whether this relationship as it currently exists, and as stated in guidelines from professional bodies, is appropriate in terms of justifiable ethical standards, empirical research and social perspectives. The results of this research will enable assessment of current guidelines and the development of further guidelines and regular process where appropriate.